Descrizione business
Nektar Therapeutics is a research-based, development stage biopharmaceutical company whose mission is to discover and develop innovative medicines to address the unmet medical needs of patients. The R&D pipeline of new investigational medicines includes treatments for cancer, auto-immune disease and chronic pain. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Howard W. Robin |
| Consiglio di amministrazione |
| Gil M. Labrucherie, Brian L. Kotzin, M.D., Dr. Dimitry S.A. Nuyten, Dr. Jonathan Zalevsky, Dr. Kevin Brodbeck, Dr. Urte Gayko, Jennifer Ruddock, Jilian B. Thomsen, John Northcott, Mark A. Wilson, Mary Tagliaferri, M.D., Robert Bacci |
| Consiglio di sorveglianza |
| Robert B. Chess, Diana M. Brainard, Dr. Myriam J. Curet, Howard W. Robin, Jeff Ajer, Karin Eastham, R. Scott Greer, Roy A. Whitfield |
Dati aziendali
| Name: |
Nektar Therapeutics Inc. |
| Indirizzo: |
455 Mission Bay Boulevard South,San Francisco, CA 94158, USA |
| Telefono: |
+1-415-482-5300 |
| Fax: |
+1-415-339-5300 |
| E-mail: |
-
|
| Internet: |
https://www.nektar.com/ |
| Industria: |
Healthcare |
| Settore: |
Pharmaceutical Industry |
| Sub settore: |
Pharmaceuticals |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
- |
| Data dell'IPO: |
- |
Rapporti con gli investitori
| Name: |
Vivian Wu |
| IR telefono: |
+1-628-895-0661 |
| IR Fax: |
- |
| IR e-mail: |
-
|
